These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 31766991)

  • 21. Tomm34 is commonly expressed in epithelial ovarian cancer and associates with tumour type and high FIGO stage.
    Muller P; Coates PJ; Nenutil R; Trcka F; Hrstka R; Chovanec J; Brychtova V; Vojtesek B
    J Ovarian Res; 2019 Mar; 12(1):30. PubMed ID: 30917858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ascites N-glycome of epithelial ovarian cancer patients.
    Biskup K; Braicu EI; Sehouli J; Tauber R; Blanchard V
    J Proteomics; 2017 Mar; 157():33-39. PubMed ID: 28188862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer.
    Zhu Q; Wu X; Wu Y; Wang X
    Oncol Rep; 2016 Dec; 36(6):3472-3478. PubMed ID: 27748885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered expression of different GalNAc‑transferases is associated with disease progression and poor prognosis in women with high-grade serous ovarian cancer.
    Sheta R; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Popa I; Bachvarov D
    Int J Oncol; 2017 Dec; 51(6):1887-1897. PubMed ID: 29039611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.
    Sopo M; Anttila M; Hämäläinen K; Kivelä A; Ylä-Herttuala S; Kosma VM; Keski-Nisula L; Sallinen H
    BMC Cancer; 2019 Jun; 19(1):584. PubMed ID: 31200683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between plasma PSGL-1 and FIGO stage, tumor metastasis, and survival in epithelial ovarian cancer.
    Li W; Fang C; Gao Y; Gao Y; Yan F; Chen B; Xu M
    Biotechnol Appl Biochem; 2024 Aug; 71(4):733-740. PubMed ID: 38494670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
    Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
    Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early inflammatory response in epithelial ovarian tumor cyst fluids.
    Kristjánsdóttir B; Partheen K; Fung ET; Yip C; Levan K; Sundfeldt K
    Cancer Med; 2014 Oct; 3(5):1302-12. PubMed ID: 24947406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors.
    Carbotti G; Orengo AM; Mezzanzanica D; Bagnoli M; Brizzolara A; Emionite L; Puppo A; Centurioni MG; Bruzzone M; Marroni P; Rossello A; Canevari S; Ferrini S; Fabbi M
    Int J Cancer; 2013 Jun; 132(11):2597-605. PubMed ID: 23169448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
    Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
    Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients.
    Huo J; Hu J; Liu G; Cui Y; Ju Y
    Arch Gynecol Obstet; 2017 Feb; 295(2):459-465. PubMed ID: 27975129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of orphan GPR56 correlates with tumor progression in human epithelial ovarian cancer.
    Liu Z; Huang Z; Yang W; Li Z; Xing S; Li H; Hu B; Li P
    Neoplasma; 2017; 64(1):32-39. PubMed ID: 27881002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYR61 overexpression associated with the development and poor prognosis of ovarian carcinoma.
    Shen H; Cai M; Zhao S; Wang H; Li M; Yao S; Jiang N
    Med Oncol; 2014 Aug; 31(8):117. PubMed ID: 25048722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Placenta Growth Factor Is Associated with Unfavorable Prognosis of Advanced-Stage Serous Ovarian Cancer.
    Meng Q; Duan P; Li L; Miao Y
    Tohoku J Exp Med; 2018 Apr; 244(4):291-296. PubMed ID: 29643276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer.
    Gong W; Liu Y; Seidl C; Diamandis EP; Kiechle M; Drecoll E; Kotzsch M; Magdolen V; Dorn J
    BMC Cancer; 2019 Jul; 19(1):696. PubMed ID: 31307411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening and identification of biomarkers in ascites related to intrinsic chemoresistance of serous epithelial ovarian cancers.
    Huang H; Li Y; Liu J; Zheng M; Feng Y; Hu K; Huang Y; Huang Q
    PLoS One; 2012; 7(12):e51256. PubMed ID: 23251472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.
    Alberti C; Pinciroli P; Valeri B; Ferri R; Ditto A; Umezawa K; Sensi M; Canevari S; Tomassetti A
    Oncogene; 2012 Sep; 31(37):4139-49. PubMed ID: 22158046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression and significance of GLUT-1 and DNA-PKcs in serous ovarian tumors].
    Cai Y; Shao SL; Wang QH; Yan LJ; Wang XY; Wang LX
    Ai Zheng; 2007 Nov; 26(11):1188-93. PubMed ID: 17991316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of Multimerin 1 (MMRN1) expression in ovarian cancer.
    Saini A; Chandra KB; Kumar V; Mathur SR; Sharma JB; Kumar S; Yadav S
    Mol Biol Rep; 2020 Dec; 47(12):9459-9468. PubMed ID: 33263168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.